Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Director's Dealing 2021

Dec 20, 2021

3695_dirs_2021-12-20_dbeb48b1-83da-433d-98e7-54a0b7bdb270.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

1 Details of the closely associated enterprise
a) Name Datum AS
2 Details of the person discharging managerial responsibilities
a) Name Jan Haudemann-Andersen
b) Position Board Member
3 Reason for notification
a) Initial notification/
Amendment
Initial
4 Details of issuer
a) Name Nykode Therapeutics AS
b) LEI 254900UKQHWYZJD22017
5 conducted Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
a) Description of the
financial instrument,
type of instrument
Shares in Nykode Therapeutics AS (ISIN: NO0010714785)
b) Nature of the
transaction
Acquisition of shares
c) Price(s) and volume(s) Price(s) Volume(s)
NOK 77.70 332,000
d) Aggregated information Price NOK 77.70
-Average price, Volume 332,000
aggregated volume and
total amount
Total amount NOK 25,796,400
e) Date of the transaction 20.12.2021
f) Place of the transaction MERK – Euronext Growth Oslo